Table 2 Frequency of treatment modalities by HIV status
From: Prognosis in HIV-infected patients with non-small cell lung cancer
Stage | HIV infected N (%) | No evidence of HIV infection N (%) | P -value |
|---|---|---|---|
Stage I–IIIA ( N =102 HIV-infected; 620 with no evidence of HIV infection) a | |||
Surgeryb | 57 (56) | 396 (64) | 0.1 |
Adjuvant chemotherapyc | 24 (24) | 104 (17) | 0.1 |
Radiation therapy for unresected tumours | 26 (25) | 146 (24) | 0.8 |
Adjuvant chemoradiotherapyd | 13 (13) | 66 (11) | 0.5 |
No treatment | 12 (12) | 68 (11) | 0.8 |
Stage IIIB–IV ( N =165 HIV infected; 808 with no evidence of HIV infection) | |||
Radiation and chemotherapye | 42 (26) | 206 (26) | 0.8 |
Lone radiation or lone chemotherapy | 73 (44) | 372 (46) | |
No treatment | 50 (30) | 230 (29) | |
